Chronic prostatitis/chronic pelvic pain syndrome explained

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
Synonyms:chronic nonbacterial prostatitis, prostatodynia, painful prostate
Field:Urology
Causes:Unknown
Differential:Bacterial prostatitis, benign prostatic hypertrophy, overactive bladder, cancer
Frequency:~4%

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), previously known as chronic nonbacterial prostatitis, is long-term pelvic pain and lower urinary tract symptoms (LUTS) without evidence of a bacterial infection. It affects about 2–6% of men.[1] Together with IC/BPS, it makes up urologic chronic pelvic pain syndrome (UCPPS).[2]

The cause is unknown.[3] Diagnosis involves ruling out other potential causes of the symptoms such as bacterial prostatitis, benign prostatic hypertrophy, overactive bladder, and cancer.[4] [5]

Recommended treatments include multimodal therapy, physiotherapy, and a trial of alpha blocker medication or antibiotics in certain newly diagnosed cases.[6] Some evidence supports some non medication based treatments.[7]

Signs and symptoms

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is characterized by pelvic or perineal pain without evidence of urinary tract infection,[8] lasting longer than 3 months,[9] as the key symptom. Symptoms may wax and wane. Pain can range from mild to debilitating. Pain may radiate to the back and rectum, making sitting uncomfortable. Pain can be present in the perineum, testicles, tip of penis, pubic or bladder area.[10] Dysuria, arthralgia, myalgia, unexplained fatigue, abdominal pain, constant burning pain in the penis, and frequency may all be present. Frequent urination and increased urgency may suggest interstitial cystitis (inflammation centred in bladder rather than prostate). Post-ejaculatory pain, mediated by nerves and muscles, is a hallmark of the condition.[11]

Cause

The cause is unknown.[3] However, there are several theories of causation.

Pelvic floor dysfunction

One theory is that CP/CPPS is a psychoneuromuscular (psychological, neurological, and muscular) disorder.[12] The theory proposes that anxiety or stress results in chronic, unconscious contraction of the pelvic floor muscles, leading to the formation of trigger points and pain.[12] The pain results in further anxiety and thus worsening of the condition.[12]

Nerves, stress and hormones

Another proposal is that it may result from an interplay between psychological factors and dysfunction in the immune, neurological, and endocrine systems.[13]

A 2016 review suggested that although the peripheral nervous system is responsible for starting the condition, the central nervous system (CNS) is responsible for continuing the pain even without continuing input from the peripheral nerves.

Theories behind the disease include stress-driven hypothalamic–pituitary–adrenal axis dysfunction and adrenocortical hormone (endocrine) abnormalities, and neurogenic inflammation.[14] [15] [16]

The role of androgens is studied in CP/CPPS,[17] with 11-oxygenated steroids (pregnanes) are presumed to be precursors to potent androgens.[18] Specifically, steroids like 11β-hydroxyprogesterone (11OHP4) and 11-ketoprogesterone (11KP4) can be converted to 11-ketodihydrotestosterone (11KDHT), an 11-oxo form of DHT with the same potency. The relationship between steroid serum levels and CP/CPPS suggests that deficiencies in the enzyme CYP21A2 may lead to increased biosynthesis of 11-oxo androgens and androgens biosynthesized via a backdoor pathway,[19] that contribute to the development of CP/CPPS. Non-classical congenital adrenal hyperplasia (CAH) resulting from CYP21A2 deficiency is typically considered asymptomatic in men. However, non-classical CAH could be a comorbidity associated with CP/CPPS.[20] [21] [22]

Bacterial infection

The bacterial infection theory was shown to be unimportant in a 2003 study which found that people with and without the condition had equal counts of similar bacteria colonizing their prostates.[23] [24]

Overlap with IC/PBS

In 2007 the NIDDK began to group IC/PBS (Interstitial Cystitis & Painful Bladder Syndrome)and CP/CPPS under the umbrella term Urologic Chronic Pelvic Pain Syndromes (UCPPS). Therapies shown to be effective in treating IC/PBS, such as quercetin,[25] have also shown some efficacy in CP/CPPS.[26] Recent research has focused on genomic and proteomic aspects of the related conditions.[27]

People may experience pain with bladder filling, which is also a typical sign of IC.[28]

The Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network has found that CPPS and bladder pain syndrome/interstitial cystitis (BPS/IC) are related conditions.[29]

Diagnosis

There are no definitive diagnostic tests for CP/CPPS. It is a poorly understood disorder, even though it accounts for 90–95% of prostatitis diagnoses.[30] CP/CPPS may be inflammatory (Category IIIa) or non-inflammatory (Category IIIb), based on levels of pus cells in expressed prostatic secretions (EPS), but these subcategories are of limited use clinically. In the inflammatory form, urine, semen, and other fluids from the prostate contain pus cells (dead white blood cells or WBCs), whereas in the non-inflammatory form no pus cells are present. Recent studies have questioned the distinction between categories IIIa and IIIb, since both categories show evidence of inflammation if pus cells are ignored and other more subtle signs of inflammation, like cytokines, are measured.[31]

In 2006, Chinese researchers found that men with categories IIIa and IIIb both had significantly and similarly raised levels of anti-inflammatory cytokine TGFβ1 and pro-inflammatory cytokine IFN-γ in their EPS when compared with controls; therefore measurement of these cytokines could be used to diagnose category III prostatitis.[32] A 2010 study found that nerve growth factor could also be used as a biomarker of the condition.[33]

For CP/CPPS patients, analysis of urine and expressed prostatic secretions for leukocytes is debatable, especially due to the fact that the differentiation between patients with inflammatory and non-inflammatory subgroups of CP/CPPS is not useful.[34] Serum PSA tests, routine imaging of the prostate, and tests for Chlamydia trachomatis and Ureaplasma provide no benefit for the patient.

Extraprostatic abdominal/pelvic tenderness is present in >50% of patients with chronic pelvic pain syndrome but only 7% of controls.[35] Healthy men have slightly more bacteria in their semen than men with CPPS.[36] The high prevalence of WBCs and positive bacterial cultures in the asymptomatic control population raises questions about the clinical usefulness of the standard Meares–Stamey four-glass test as a diagnostic tool in men with CP/CPPS.[36] By 2000, the use of the four-glass test by American urologists was rare, with only 4% using it regularly.[37]

Men with CP/CPPS are more likely than the general population to have Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)[38] and irritable bowel syndrome (IBS).

Experimental tests that could be useful in the future include tests to measure semen and prostate fluid cytokine levels. Various studies have shown increases in markers for inflammation such as elevated levels of cytokines,[39] [40] myeloperoxidase,[41] and chemokines.[42]

Differential diagnosis

Some conditions have similar symptoms to chronic prostatitis: bladder neck hypertrophy and urethral stricture may both cause similar symptoms through urinary reflux (inter alia) and can be excluded through flexible cystoscopy and urodynamic tests.[43] [44] [45]

Nomenclature

A distinction is sometimes made between "IIIa" (Inflammatory) and "IIIb" (Noninflammatory) forms of CP/CPPS,[46] depending on whether pus cells (WBCs) can be found in the expressed prostatic secretions (EPS) of the patient. Some researchers have questioned the usefulness of this categorisation, calling for the Meares–Stamey four-glass test to be abandoned.[47]

In 2007, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) began using the umbrella term urologic chronic pelvic pain syndromes (UCPPS), for research purposes, to refer to pain syndromes associated with the bladder (i.e. interstitial cystitis/painful bladder syndrome, IC/PBS) and the prostate gland (i.e. chronic prostatitis/chronic pelvic pain syndrome, CP/CPPS).[48]

Older terms for this condition are "prostatodynia" (prostate pain) and non-bacterial chronic prostatitis. These terms are no longer in use.[49]

Symptom classification

A classification system called "UPOINT" was developed by urologists Shoskes and Nickel to allow clinical profiling of a patient's symptoms into six broad categories:[50]

The UPOINT system allows for individualized and multimodal therapy.[52]

Treatment

Chronic pelvic pain syndrome is difficult to treat.[53] Initial recommendations include education regarding the condition, stress management, and behavioral changes.[54]

Non-drug treatments

Current guidelines by the European Association of Urology include:[55]

Other non-drug treatments that have been evaluated for this condition include acupuncture, extracorporeal shockwave therapy, programs for physical activity, transrectal thermotherapy and a different set of recommendations regarding lifestyle changes. Acupuncture probably leads to a decrease in prostatitis symptoms when compared with standard medical therapy but may not reduce sexual problems. When compared with a simulated procedure, extracorporeal shockwave therapy also appears to be helpful in decreasing prostate symptoms without the impact of negative side effects but the decrease may only last while treatment is continued. As of 2018 use of extracorporeal shockwave therapy had been studied as a potential treatment for this condition in three small studies; there were short term improvements in symptoms and few adverse effects, but the medium terms results are unknown, and the results are difficult to generalize due to low quality of the studies. Physical activity may slightly reduce physical symptoms of chronic prostatitis but may not reduce anxiety or depression. Transrectal thermotherapy, where heat is applied to the prostate and pelvic muscle area, on its own or combined with medical therapy may cause symptoms to decrease slightly when compared with medical therapy alone. However, this method may lead to transient side effects. Alternative therapies like prostate massage or lifestyle modifications may or may not reduce symptoms of prostatitis. Transurethral needle ablation of the prostate has been shown to be ineffective in trials.[59]

Neuromodulation has been explored as a potential treatment option for some time. Traditional spinal cord stimulation, also known as dorsal column stimulation has been inconsistent in treating pelvic pain: there is a high failure rate with these traditional systems due to the inability to affect all of the painful areas and there remains to be consensus on where the optimal location of the spinal cord this treatment should be aimed. As the innervation of the pelvic region is from the sacral nerve roots, previous treatments have been aimed at this region; however pain pathways seem to elude treatment solely directed at the level of the spinal cord (perhaps via the sympathetic nervous system) leading to failures.[60] Spinal cord stimulation aimed at the mid- to high-thoracic region of the spinal cord have produced some positive results. A newer form of spinal cord stimulation called dorsal root ganglion stimulation (DRG) has shown a great deal of promise for treating pelvic pain due to its ability to affect multiple parts of the nervous system simultaneously – it is particularly effective in patients with "known cause" (i.e. post surgical pain, endometriosis, pudendal neuralgia, etc.).[61] [62]

Medications

A number of medications can be used which need to be tailored to each person's needs and types of symptoms (according to UPOINTS, S = sexual: e.g. erectile dysfunction, ejaculatory dysfunction, postorgasmic pain).

Emerging research

In a preliminary 2005 open label study of 16 treatment-recalcitrant CPPS patients, controversial entities known as nanobacteria were proposed as a cause of prostatic calcifications found in some CPPS patients.[73] Patients were given EDTA (to dissolve the calcifications) and three months of tetracycline (a calcium-leaching antibiotic with anti-inflammatory effects,[74] used here to kill the "pathogens"), and half had significant improvement in symptoms. Scientists have expressed strong doubts about whether nanobacteria are living organisms,[75] and research in 2008 showed that "nanobacteria" are merely tiny lumps of abiotic limestone.[76] [77]

The evidence supporting a viral cause of prostatitis and chronic pelvic pain syndrome is weak. Single case reports have implicated herpes simplex virus (HSV) and cytomegalovirus (CMV), but a study using PCR failed to demonstrate the presence of viral DNA in patients with chronic pelvic pain syndrome undergoing radical prostatectomy for localized prostate cancer.[78] The reports implicating CMV must be interpreted with caution, because in all cases the patients were immunocompromised.[79] [80] [81] For HSV, the evidence is weaker still, and there is only one reported case, and the causative role of the virus was not proven,[82] and there are no reports of successful treatments using antiviral drugs such as aciclovir.

Due to the concomitant presence of bladder disorders, gastrointestinal disorders and mood disorders, research has been conducted to understand whether CP/CPPS might be caused by problems with the hypothetical bladder-gut-brain axis.[83]

Research has been conducted to understand how chronic bladder pain affects the brain, using techniques like MRI and functional MRI; as of 2016, it appeared that males with CP/CPPS have increased grey matter in the primary somatosensory cortex, the insular cortex and the anterior cingulate cortex and in the central nucleus of the amygdala; studies in rodents have shown that blocking the metabotropic glutamate receptor 5, which is expressed in the central nucleus of the amygdala, can block bladder pain.[84]

Prognosis

In recent years, the prognosis for CP/CPPS has improved with the advent of multimodal treatment, phytotherapy, protocols aimed at quieting the pelvic nerves through myofascial trigger point release, anxiety control and chronic pain therapy.[85] [86] [87]

Epidemiology

In the general population, chronic pelvic pain syndrome occurs in about 0.5% of men in a given year.[88] It is found in men of any age, with the peak incidence in men aged 35–45 years.[89] However, the overall prevalence of symptoms suggestive of CP/CPPS is 6.3%.[90] The role of the prostate was questioned in the cause of CP/CPPS when both men and women in the general population were tested using the (1) National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI[91])with the female homologue of each male anatomical term used on questionnaires for female participants (2) the International Prostate Symptom Score (IPSS), and (3) additional questions on pelvic pain. The prevalence of symptoms suggestive of CPPS in this selected population was 5.7% in women and 2.7% in men, placing in doubt the role of the prostate gland.[92] New evidence from 2008 suggests that the prevalence of CP/CPPS is much higher in teenage males than once suspected.[93]

Society and culture

Notable cases have included:

Notes and References

  1. Doiron . RC . Nickel . JC . Management of chronic prostatitis/chronic pelvic pain syndrome . Canadian Urological Association Journal . June 2018 . 12 . 6 Suppl 3 . S161–S163 . 10.5489/cuaj.5325 . 29875042. 6040620 .
  2. Adamian L, Urits I, Orhurhu V, Hoyt D, Driessen R, Freeman JA, Kaye AD, Kaye RJ, Garcia AJ, Cornett EM, Viswanath O . A Comprehensive Review of the Diagnosis, Treatment, and Management of Urologic Chronic Pelvic Pain Syndrome . Curr Pain Headache Rep . 24 . 6 . 27 . May 2020 . 32378039 . 10.1007/s11916-020-00857-9 . 218513050 .
  3. Franco . Juan VA . Turk . Tarek . Jung . Jae Hung . Xiao . Yu-Tian . Iakhno . Stanislav . Garrote . Virginia . Vietto . Valeria . Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome . Cochrane Database of Systematic Reviews . 12 May 2018 . 2018 . 5 . CD012551 . 10.1002/14651858.CD012551.pub3 . 29757454 . 6494451 .
  4. Doiron . RC . Nickel . JC . Evaluation of the male with chronic prostatitis/chronic pelvic pain syndrome . Canadian Urological Association Journal . June 2018 . 12 . 6 Suppl 3 . S152–S154 . 10.5489/cuaj.5322 . 29875039. 6040610 .
  5. 26926816 . 93 . 4 . Common Questions About Chronic Prostatitis . 2016 . Am Fam Physician . 290–296 . Holt JD, Garrett WA, McCurry TK, Teichman JM .
  6. Book: Ferri . Fred F. . Ferri's Clinical Advisor 2019 E-Book: 5 Books in 1 . 2018 . Elsevier Health Sciences . 9780323550765 . 1149 . en . 2020-09-19 . 2023-06-30 . https://web.archive.org/web/20230630084745/https://books.google.com/books?id=-L5dDwAAQBAJ&pg=PA1149 . live .
  7. Franco. Juan Va. Turk. Tarek. Jung. Jae Hung. Xiao. Yu-Tian. Iakhno. Stanislav. Garrote. Virginia. Vietto. Valeria. 12 May 2018. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. The Cochrane Database of Systematic Reviews. 2018. 5 . CD012551. 10.1002/14651858.CD012551.pub3. 1469-493X. 6494451. 29757454.
  8. Schaeffer AJ . Epidemiology and evaluation of chronic pelvic pain syndrome in men . Int J Antimicrob Agents . 31. 2007 . 18164597 . 10.1016/j.ijantimicag.2007.08.027 . S108–S111.
  9. Luzzi GA . Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management . Journal of the European Academy of Dermatology and Venereology . 16 . 3 . 253–256 . 2002 . 12195565 . 10.1046/j.1468-3083.2002.00481.x. 5748689 .
  10. Clemens, J Quentin . Meenan, Richard T . O'Keeffe Rosetti, Maureen C . Gao, Sara Y . Calhoun, Elizabeth A . Dec 2005 . Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community . J Urol . 174 . 6 . 2319–2322 . 10.1097/01.ju.0000182152.28519.e7. 16280832 .
  11. Shoskes DA, Landis JR, Wang Y, Nickel JC, Zeitlin SI, Nadler R. Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome . J. Urol. . 172 . 2 . 542–547 . August 2004 . 15247725 . 10.1097/01.ju.0000132798.48067.23.
  12. Anderson. RU. Wise. D. Nathanson. NH. October 2018. Chronic Prostatitis and/or Chronic Pelvic Pain as a Psychoneuromuscular Disorder – A Meta-analysis. Urology. 120. 23–29. 10.1016/j.urology.2018.07.022. 30056195. 51864355 .
  13. Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome . J. Urol. . 179 . 5 Suppl . S61–S67 . May 2008 . 18405756 . 10.1016/j.juro.2008.03.139 . 3591463 .
  14. Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress . J. Neuroimmunol. . 146 . 1–2 . 1–12 . 2004 . 14698841 . 10.1016/j.jneuroim.2003.10.041. 6866545 .
  15. Theoharides TC, Kalogeromitros D. The critical role of mast cells in allergy and inflammation . Ann. N.Y. Acad. Sci. . 1088 . 1. 78–99 . 2006 . 17192558 . 10.1196/annals.1366.025 . 2006NYASA1088...78T . 7659928 .
  16. Sant GR, Kempuraj D, Marchand JE, Theoharides TC. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis . Urology . 69 . 4 Suppl . 34–40 . 2007 . 17462477 . 10.1016/j.urology.2006.08.1109 . 10.1.1.383.9862 .
  17. Luu-The V, Bélanger A, Labrie F . Androgen biosynthetic pathways in the human prostate . Best Pract Res Clin Endocrinol Metab . 22 . 2 . 207–221 . April 2008 . 18471780 . 10.1016/j.beem.2008.01.008 .
  18. Dimitrakov J, Joffe HV, Soldin SJ, Bolus R, Buffington CA, Nickel JC. 2008. Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology. 71. 2. 261–266. 10.1016/j.urology.2007.09.025. 2390769. 18308097.
  19. Web site: Precision Medicine in Urology: Molecular Mechanisms, Diagnostics and Therapeutic Targets . 2330-1910 . 2024-02-05 . 2024-02-05 . https://web.archive.org/web/20240205155735/https://e-century.us/files/ajceu/Report_of_SBUR_2018_Annual_Meeting.pdf . live .
  20. du Toit T, Swart AC. 2020. The 11β-hydroxyandrostenedione pathway and C11-oxy C21 backdoor pathway are active in benign prostatic hyperplasia yielding 11keto-testosterone and 11keto-progesterone. The Journal of Steroid Biochemistry and Molecular Biology. 196. 105497. 10.1016/j.jsbmb.2019.105497. 31626910. 204734045.
  21. 2022. Letter to the editor regarding the article "Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome". Urology. English. 10.1016/j.urology.2022.07.051. 0090-4295. 35987379. 251657694. 169. 273. Masiutin MG, Yadav MK. subscription. 2022-10-20. 2023-06-30. https://web.archive.org/web/20230630084752/https://www.goldjournal.net/article/S0090-4295%2822%2900690-2/fulltext. live.
  22. 2022. Author reply. Urology. English. 10.1016/j.urology.2022.07.049. 35985522. 251658492. 0090-4295. 169. 273–274. Dimitrakoff J, Nickel JC. subscription. 2022-10-20. 2023-06-30. https://web.archive.org/web/20230630084753/https://www.goldjournal.net/article/S0090-4295%2822%2900691-4/fulltext. live.
  23. Lee JC . Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls . J. Urol. . 169 . 2 . 584–587; discussion 587–588 . February 2003 . 12544312 . 10.1016/s0022-5347(05)63958-4. Muller CH . Rothman I . etal . 10.1.1.605.5540 .
  24. Schaeffer AJ. Editorial: Emerging concepts in the management of prostatitis/chronic pelvic pain syndrome. J. Urol.. 2003. 169. 2. 597–598. 12544315 . 10.1016/S0022-5347(05)63961-4 .
  25. Theoharides . TC. . Whitmore . K. . Stanford . E. . Moldwin . R. . O'Leary . MP. . Interstitial cystitis: bladder pain and beyond . Expert Opin Pharmacother . 9 . 17 . 2979–2994 . Dec 2008 . 10.1517/14656560802519845 . 19006474 . 10.1.1.470.7817 . 73881007 .
  26. Murphy . AB. . Macejko . A. . Taylor . A. . Nadler . RB. . Chronic prostatitis: management strategies . Drugs . 69 . 1 . 71–84 . 2009 . 10.2165/00003495-200969010-00005 . 19192937 . 13127203 .
  27. Dimitrakov . J. . Dimitrakova . E. . Urologic chronic pelvic pain syndromelooking back and looking forward . Folia Med (Plovdiv) . 51 . 3 . 42–44 . 2009. 19957562 .
  28. Rourke W, Khan SA, Ahmed K, Masood S, Dasgupta P, Khan MS. Painful bladder syndrome/interstitial cystitis: aetiology, evaluation and management . Arch Ital Urol Androl . 86 . 2 . 126–131 . June 2014 . 25017594 . 10.4081/aiua.2014.2.126. free . 30355982 .
  29. Web site: A New Look at Urological Chronic Pelvic Pain . MAPP Network . Perelman School of Medicine at the University of Pennsylvania . 23 June 2020 . 10 August 2020 . https://web.archive.org/web/20200810013308/https://www.mappnetwork.org/ . live .
  30. Habermacher GM, Chason JT, Schaeffer AJ. Prostatitis/chronic pelvic pain syndrome . Annu. Rev. Med. . 57 . 195–206 . 2006 . 16409145 . 10.1146/annurev.med.57.011205.135654.
  31. A Pontari . M. . Inflammation and anti-inflammatory therapy in chronic prostatitis . Urology . 60 . 6 Suppl . 29–33; discussion 33–34 . Dec 2002 . 10.1016/S0090-4295(02)02381-6. 12521589 . 10.1.1.383.9485 .
  32. Ding XG, Li SW, Zheng XM, Hu LQ. [IFN-gamma and TGF-beta1, levels in the EPS of patients with chronic abacterial prostatitis] . zh . Zhonghua Nan Ke Xue . 12 . 11 . 982–984 . 2006 . 17146921.
  33. Watanabe . T. . Inoue . M. . Sasaki . K. . Araki . M. . Uehara . S. . Monden . K. . Saika . T. . Nasu . Y. . Kumon . H. . Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment . BJU Int . 108. 2. 248–251. Sep 2010 . 10.1111/j.1464-410X.2010.09716.x . 20883485 . Chancellor . Michael B. . 6979830 . free .
  34. Weidner W, Anderson RU. Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation . Int J Antimicrob Agents . 31. 2. 2007 . 18162376 . 10.1016/j.ijantimicag.2007.07.044 . S91–S95.
  35. Shoskes DA, Berger R, Elmi A, Landis JR, Propert KJ, Zeitlin S. Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study . J. Urol. . 179 . 2 . 556–560 . 2008 . 18082223 . 10.1016/j.juro.2007.09.088 . 2664648.
  36. Nickel JC, Alexander RB, Schaeffer AJ, Landis JR, Knauss JS, Propert KJ. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls . J. Urol. . 170 . 3 . 818–822 . 2003 . 12913707 . 10.1097/01.ju.0000082252.49374.e9.
  37. McNaughton Collins . M. . Fowler . FJ. . Elliott . DB. . Albertsen . PC. . Barry . MJ. . Diagnosing and treating chronic prostatitis: do urologists use the four-glass test? . Urology . 55 . 3 . 403–407 . Mar 2000 . 10.1016/S0090-4295(99)00536-1. 10699621 .
  38. Leslie A Aaron. Comorbid Clinical Conditions in Chronic Fatigue: A Co-Twin Control Study. J Gen Intern Med. 2001. 16. 1. 24–31. 11251747 . 10.1111/j.1525-1497.2001.03419.x . 1495162. etal .
  39. Khadra . A. . Fletcher . P. . Luzzi . G. . Shattock . R. . Hay . P. . Interleukin-8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis . BJU Int . 97 . 5 . 1043–1046 . May 2006 . 10.1111/j.1464-410X.2006.06133.x . 16643489 . 22660010 .
  40. He . L. . Wang . Y. . Long . Z. . Jiang . C. . Clinical Significance of IL-2, IL-10, and TNF-alpha in Prostatic Secretion of Patients With Chronic Prostatitis . Urology . 75. 3. 654–657. Dec 2009 . 10.1016/j.urology.2009.09.061 . 19963254 .
  41. Pasqualotto . FF. . Sharma . RK. . Potts . JM. . Nelson . DR. . Thomas . AJ. . Agarwal . A. . Seminal oxidative stress in patients with chronic prostatitis . Urology . 55 . 6 . 881–885 . Jun 2000 . 10.1016/S0090-4295(99)00613-5. 10840100 .
  42. Penna . G. . Mondaini . N. . Amuchastegui . S. . Degli Innocenti . S. . Carini . M. . Giubilei . G. . Fibbi . B. . Colli . E. . Maggi . M. . Adorini . Luciano . Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia . Eur Urol . 51 . 2 . 524–533; discussion 533 . Feb 2007 . 10.1016/j.eururo.2006.07.016 . 16905241 . 2158/687725 . free .
  43. Chiari R . Urethral obstruction and prostatitis . Int Urol Nephrol . 15 . 3 . 245–255 . 1983 . 6654631 . 10.1007/BF02083011. 7080545 .
  44. Hruz P, Danuser H, Studer UE, Hochreiter WW. Non-inflammatory chronic pelvic pain syndrome can be caused by bladder neck hypertrophy . Eur. Urol. . 44 . 1 . 106–110; discussion 110 . 2003 . 12814683 . 10.1016/S0302-2838(03)00203-3.
  45. Romero Pérez P, Mira Llinares A. [Complications of the lower urinary tract secondary to urethral stenosis] . es. Actas Urol Esp . 20 . 9 . 786–793 . 1996 . 9065088.
  46. Web site: Prostatitis: Benign Prostate Disease: Merck Manual Professional . 2010-04-17 . 2010-04-28 . https://web.archive.org/web/20100428071924/http://www.merck.com/mmpe/sec17/ch240/ch240c.html . live .
  47. Treatment of Chronic Prostatitis . 2010-04-18 . Nat Clin Pract Urol . 2004 . 1 . 1 . 2017-04-27 . https://web.archive.org/web/20170427082114/http://www.medscape.com/viewarticle/494378 . live .
  48. Web site: Multi-disciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. 2008-01-11. NIDDK. 2007. 2007-10-27. https://web.archive.org/web/20071027140854/http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-07-003.html. live.
  49. Hochreiter W, Bader P . Etiopathogenesis of prostatitis . German . Urologe A . 40 . 1 . 4–8 . January 2001 . 11225430 . 10.1007/s001200050424 . 967732 .
  50. Shoskes DA, Nickel JC, Dolinga R, Prots D . Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity . Urology . 73 . 3 . 538–542; discussion 542–543 . 2009 . 19118880 . 10.1016/j.urology.2008.09.074 . 10.1.1.384.4216 .
  51. Sandhu J, Tu HV . Recent advances in managing chronic prostatitis/chronic pelvic pain syndrome . F1000Res . 6 . 1747. 2017 . 29034074 . 5615772 . 10.12688/f1000research.10558.1 . free .
  52. Doiron RC, Shoskes DA, Nickel JC . Male CP/CPPS: where do we stand? . World J Urol . 37 . 6 . 1015–1022 . June 2019 . 30864007 . 10.1007/s00345-019-02718-6 . 76662118 .
  53. Potts . J . Payne. RE . Prostatitis: Infection, neuromuscular disorder, or pain syndrome? Proper patient classification is key . Cleveland Clinic Journal of Medicine . 74 . Suppl 3 . 63–71 . May 2007 . 17549825 . 10.3949/ccjm.74.Suppl_3.S63 .
  54. Web site: 2014. Diagnosis and Treatment Interstitial Cystitis/Bladder Pain Syndrome. 15 July 2018. www.auanet.org. en. 20 September 2018. https://web.archive.org/web/20180920145129/https://www.auanet.org/guidelines/interstitial-cystitis/bladder-pain-syndrome-(2011-amended-2014). dead.
  55. Web site: Professionals. Sumedia-Online. EAU Guidelines: Chronic Pelvic Pain. 2021-02-28. Uroweb. en-US. 2021-01-16. https://web.archive.org/web/20210116080442/https://uroweb.org/guideline/chronic-pelvic-pain/. live.
  56. News: McNeil. Donald G.. 30 December 2013. A Fix for Stress-Related Pelvic Pain. The New York Times. en. 15 July 2018. 27 March 2019. https://web.archive.org/web/20190327122522/https://www.nytimes.com/2013/12/31/health/a-fix-for-stress-related-pelvic-pain.html. live.
  57. Champaneria . Rita . Daniels . Jane P. . Raza . Amer . Pattison . Helen M. . Khan . Khalid S. . Psychological therapies for chronic pelvic pain: systematic review of randomized controlled trials: Psychological therapies for chronic pelvic pain . Acta Obstetricia et Gynecologica Scandinavica . March 2012 . 91 . 3 . 281–286 . 10.1111/j.1600-0412.2011.01314.x . 22050516 . 28767715 . free .
  58. Cheong . Ying C . Smotra . Grisham . Williams . Amanda C de C . Non-surgical interventions for the management of chronic pelvic pain . Cochrane Database of Systematic Reviews . 5 March 2014 . 2014 . 3 . CD008797 . 10.1002/14651858.CD008797.pub2 . 24595586. 10981791 .
  59. Leskinen . MJ. . Kilponen . A. . Lukkarinen . O. . Tammela . TL. . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham-controlled study . Urology . 60 . 2 . 300–304 . Aug 2002 . 10.1016/S0090-4295(02)01704-1. 12137830 .
  60. Hunter . Corey W. . Stovall . Brad . Chen . Grant . Carlson . Jonathan . Levy . Robert . March 2018 . Anatomy, Pathophysiology and Interventional Therapies for Chronic Pelvic Pain: A Review . Pain Physician . 21 . 2 . 147–167 . 10.36076/ppj.2018.2.147 . 2150-1149 . 29565946. free .
  61. Hunter . Corey W. . Falowski . Steven . 2021-02-03 . Neuromodulation in Treating Pelvic Pain . Current Pain and Headache Reports . en . 25 . 2 . 9 . 10.1007/s11916-020-00927-y . 33534006 . 231787453 . 1534-3081. subscription .
  62. Hunter . Corey W. . Yang . Ajax . January 2019 . Dorsal Root Ganglion Stimulation for Chronic Pelvic Pain: A Case Series and Technical Report on a Novel Lead Configuration . Neuromodulation: Journal of the International Neuromodulation Society . 22 . 1 . 87–95 . 10.1111/ner.12801 . 1525-1403 . 30067887 . 51892311 . 2022-03-07 . 2023-02-15 . https://web.archive.org/web/20230215003416/https://pubmed.ncbi.nlm.nih.gov/30067887/ . live .
  63. Franco. Juan VA. Turk. Tarek. Jung. Jae Hung. Xiao. Yu-Tian. Iakhno. Stanislav. Tirapegui. Federico Ignacio. Garrote. Virginia. Vietto. Valeria. 2019-10-06. Cochrane Urology Group. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database of Systematic Reviews. 2019. 10. CD012552. en. 10.1002/14651858.CD012552.pub2. 6778620. 31587256.
  64. Anothaisintawee. T. Attia, J. Nickel, JC. Thammakraisorn, S. Numthavaj, P. McEvoy, M. Thakkinstian, A. Jan 5, 2011. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA: The Journal of the American Medical Association. 305. 1. 78–86. 10.1001/jama.2010.1913. 21205969. free.
  65. Wagenlehner . FM. . Naber . KG. . Bschleipfer . T. . Brähler . E. . Weidner . W. . Prostatitis and male pelvic pain syndrome: diagnosis and treatment . Dtsch Ärztebl Int . 106 . 11 . 175–183 . Mar 2009 . 10.3238/arztebl.2009.0175 . 19568373 . 2695374 .
  66. Shoskes DA . Use of antibiotics in chronic prostatitis syndromes . Can J Urol . 8 . 24–28 . June 2001 . Suppl 1 . 11442994 .
  67. Yang G, Wei Q, Li H, Yang Y, Zhang S, Dong Q. The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials . J. Androl. . 27 . 6 . 847–852 . 2006 . 16870951 . 10.2164/jandrol.106.000661 . ...treatment duration should be long enough (more than 3 months). free .
  68. Cohen JM, Fagin AP, Hariton E, Niska JR, Pierce MW, Kuriyama A, Whelan JS, Jackson JL, Dimitrakoff JD . Therapeutic Intervention for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/ CPPS): A Systematic Review and Meta-Analysis . PLOS ONE . 7 . 8 . 2012 . 22870266 . 10.1371/journal.pone.0041941. 2012PLoSO...741941C . e41941 . 3411608. free .
  69. Dhar NB, Shoskes DA . New therapies in chronic prostatitis . Curr Urol Rep . 8 . 4 . 313–318 . 2007 . 18519016 . 10.1007/s11934-007-0078-5. 195365395 .
  70. Capodice JL, Bemis DL, Buttyan R, Kaplan SA, Katz AE . Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome . Evid Based Complement Alternat Med . 2 . 4 . 495–501 . 2005 . 16322807 . 1297501 . 10.1093/ecam/neh128 .
  71. Management of Men Diagnosed With Chronic Prostatitis/Chronic Pelvic Pain Syndrome Who Have Failed Traditional Management . 1892625 . 2007 . 9 . 2 . 17592539 . Curtis Nickel . J . Baranowski . AP . Pontari . M . Berger . RE . Tripp . DA . 63–72 . Reviews in Urology .
  72. Larish . Alyssa M. . Dickson . Rozalin R. . Kudgus . Rachel A. . McGovern . Renee M. . Reid . Joel M. . Hooten . W. Michael . Nicholson . Wayne T. . Vaughan . Lisa E. . Burnett . Tatnai L. . Laughlin-Tommaso . Shannon K. . Faubion . Stephanie S. . June 2019 . Vaginal Diazepam for Nonrelaxing Pelvic Floor Dysfunction: The Pharmacokinetic Profile . The Journal of Sexual Medicine . 16 . 6 . 763–766 . 10.1016/j.jsxm.2019.03.003 . 1743-6109 . 31010782 . 128361154 . 2022-03-07 . 2023-02-18 . https://web.archive.org/web/20230218112735/https://pubmed.ncbi.nlm.nih.gov/31010782/ . live .
  73. Shoskes DA, Thomas KD, Gomez E. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience . J. Urol. . 173 . 2 . 474–477 . 2005 . 15643213. 10.1097/01.ju.0000150062.60633.b2. 10.1.1.384.2090 .
  74. Rempe . S . Hayden . JM . Robbins . RA . Hoyt . JC . Tetracyclines and Pulmonary Inflammation . Endocrine, Metabolic & Immune Disorders Drug Targets . 30 November 2007 . 7 . 4 . 232–236 . 10.2174/187153007782794344 . 18220943 .
  75. Urbano P, Urbano F. Nanobacteria: facts or fancies? . PLOS Pathogens . 3 . 5 . e55 . 2007 . 17530922. 10.1371/journal.ppat.0030055 . 1876495 . free .
  76. Hopkin . Michael . Nanobacteria theory takes a hit . Nature . 17 April 2008 . 10.1038/news.2008.762 .
  77. Martel . J. . Young . J. D.-E . Purported nanobacteria in human blood as calcium carbonate nanoparticles . Proceedings of the National Academy of Sciences . 8 April 2008 . 105 . 14 . 5549–5554 . 10.1073/pnas.0711744105 . 18385376 . 2291092 . 2008PNAS..105.5549M . free .
  78. Leskinen MJ . Herpes simplex virus, cytomegalovirus, and papillomavirus DNA are not found in patients with chronic pelvic pain syndrome undergoing radical prostatectomy for localized prostate cancer . Urology . 61 . 2 . 397–401. 2003 . 12597955 . 10.1016/S0090-4295(02)02166-0. Vainionp R . Syrjnen S . etal .
  79. Benson PJ, Smith CS. Cytomegalovirus prostatitis. Case report and review of the literature. Urology . 40 . 2 . 165–167 . 1992 . 1323895 . 10.1016/0090-4295(92)90520-7.
  80. Mastroianni A, Coronado O, Manfredi R, Chiodo F, Scarani P. Acute cytomegalovirus prostatitis in AIDS . Genitourinary Medicine . 72 . 6 . 447–448 . 1996 . 9038649 . 10.1136/sti.72.6.447. 1195741.
  81. McKay TC, Albala DM, Sendelbach K, Gattuso P. Cytomegalovirus prostatitis. Case report and review of the literature . International Urology and Nephrology . 26 . 5 . 535–540 . 1994 . 7860201 . 10.1007/bf02767655. 7268832 .
  82. Doble A, Harris JR, Taylor-Robinson D. Prostatodynia and herpes simplex virus infection . Urology . 38 . 3 . 247–248 . 1991 . 1653479 . 10.1016/S0090-4295(91)80355-B.
  83. Leue. C. Kruimel. J. Vrijens. D. Masclee. A. van Os. J. van Koeveringe. G. Functional urological disorders: a sensitized defence response in the bladder-gut-brain axis.. Nature Reviews. Urology. March 2017. 14. 3. 153–163. 10.1038/nrurol.2016.227. 27922040. 2016916.
  84. Sadler. KE. Kolber. BJ. Urine Trouble: Alterations in Brain Function Associated with Bladder Pain.. The Journal of Urology. July 2016. 196. 1. 24–32. 10.1016/j.juro.2015.10.198. 26905019. 4914416.
  85. Duclos . AJ. . Lee . CT. . Shoskes . DA. . Current treatment options in the management of chronic prostatitis . Ther Clin Risk Manag . 3 . 4 . 507–512 . Aug 2007 . 18472971 . 2374945 .
  86. Shoskes . DA. . Katz . E. . Multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome . Curr Urol Rep . 6 . 4 . 296–299 . Jul 2005 . 10.1007/s11934-005-0027-0. 15978233 . 195366261 .
  87. Bergman . J. . Zeitlin . SI. . Prostatitis and chronic prostatitis/chronic pelvic pain syndrome . Expert Rev Neurother . 7 . 3 . 301–307 . Mar 2007 . 10.1586/14737175.7.3.301 . 17341178 . 24426243 .
  88. Taylor BC . Excessive antibiotic use in men with prostatitis . Am. J. Med. . 121 . 5 . 444–449 . May 2008 . 18456041 . 2409146 . 10.1016/j.amjmed.2008.01.043 . Noorbaloochi S . McNaughton-Collins M . etal .
  89. Book: Chronic Prostatitis/Chronic Pelvic Pain Syndrome . 171 . Daniel Shoskes . 978-1-934115-27-5 . 2008 . Humana Press . 2016-09-23 . 2023-06-30 . https://web.archive.org/web/20230630085253/https://books.google.com/books?id=tHZ9thCt4skC&pg=PT171 . live .
  90. Daniels NA, Link CL, Barry MJ, McKinlay JB. Association between past urinary tract infections and current symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome . J Natl Med Assoc . 99 . 5 . 509–516 . May 2007 . 17534008 . 2576075.
  91. Web site: NIH CPSI . Urologic Chronic Pelvic Pain Syndrome (UCPPS) archive . 2009-11-10 . 2021-04-10 . https://web.archive.org/web/20210410222344/https://www.ucpps.men/1/cpsi.html . live .
  92. Marszalek M, Wehrberger C, Temml C, Ponholzer A, Berger I, Madersbacher S. Chronic Pelvic Pain and Lower Urinary Tract Symptoms in Both Sexes: Analysis of 2749 Participants of an Urban Health Screening Project . Eur. Urol. . 55. 2. 499–507. April 2008 . 18395963 . 10.1016/j.eururo.2008.03.073.
  93. Nickel . JC. . Tripp . DA. . Chuai . S. . Litwin . MS. . McNaughton-Collins . M. . Landis . JR. . Alexander . RB. . Schaeffer . AJ. . O'Leary . MP. . Pontari . Michel A. . White . Paige . Mullins . Christopher . Nyberg . Leroy . Kusek . John . Nih-Cpcrn Study . Group . Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome . BJU Int . 101 . 1 . 59–64 . Jan 2008 . 10.1111/j.1464-410X.2007.07196.x . 17924985 . 13568744 .
  94. Web site: Anderson goes. 2008-05-12. Australian Broadcasting Corporation Transcript. 2005-06-23. 2016-10-28. https://web.archive.org/web/20161028041057/http://www.abc.net.au/lateline/content/2005/s1399437.htm. live.
  95. Book: The Intimate Sex Lives of Famous People. 2010-12-21. Doubleday. 9781932595291. 2008.
  96. Web site: John Cleese tour pays the 'Alimony' with West Coast comedy shows . 2009-07-28 . tickenews.com . Allison Reitz . July 2009 . http://web.archive.org/web/20090728000000/http://www.johncleese.org/images/John-Cleese-Picture.jpg . 2009-07-28 . The star of Monty Python and "A Fish Called Wanda" has been diagnosed with prostatitis, the inflammation of the prostate gland and is undergoing treatment.. Alt URL
  97. Web site: The whole truth from Vincent Gallour Flies. 2008-05-30. Chicago Sun Times. Roger Ebert. https://web.archive.org/web/20080513175438/http://www.galloappreciation.com/print/chicagosuntimes.html. 2008-05-13. dead.
  98. Web site: Glenn Gould as Patient . 2008-05-12 . https://web.archive.org/web/20080607111041/http://www.collectionscanada.gc.ca/glenngould/028010-502.17-e.html . 2008-06-07 . dead .
  99. Book: Dallek, Robert. An Unfinished Life: John F. Kennedy 1917–1963. 2003. 123. Little, Brown. Boston. 978-0-316-17238-7. registration.
  100. News: Jeffries . Stuart . Teach Us to Sit Still: A Sceptic's Search for Health and Healing by Tim Parks . 10 May 2019 . The Guardian . 3 July 2010 . 10 May 2019 . https://web.archive.org/web/20190510210018/https://www.theguardian.com/books/2010/jul/03/teach-sit-still-tim-parks . live .
  101. News: Astier . Henri . Prostatitis: 'How I meditated away chronic pelvic pain' . 10 May 2019 . BBC . 7 May 2019 . https://web.archive.org/web/20190507204429/https://www.bbc.com/news/health-44910438 . live .
  102. Web site: The Howard Stern Show for September 4, 2007. 2008-05-12. Howard Stern. 2013-03-21. https://web.archive.org/web/20130321223510/http://howardstern.com/rundown.hs?d=1188878400. live.
  103. Web site: The Howard Stern Show for September 5, 2007, Pulling Out a Plum. 2008-05-12. Howard Stern. 2013-03-21. https://web.archive.org/web/20130321222557/http://howardstern.com/rundown.hs?d=1188964800. live.
  104. News: Styron's Choices. 2008-05-12. NY Times. David. Leavitt. 2008-05-11. 2011-05-02. https://web.archive.org/web/20110502065436/http://www.nytimes.com/2008/05/11/books/review/Leavitt-t.html. live.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Chronic prostatitis/chronic pelvic pain syndrome".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.